皮肤上生长因子受体的抑制导致DSP突变的皮细胞的细胞表型纠正
Daniela Andrei1, Jeroen Bremer1, Duco Kramer1
1Department of Dermatology, Expertise Center for Blistering Diseases, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Experimental dermatology
|March 21, 2024
概括
一种新的desmoplakin (DSP) 基因变异导致皮肤和心脏疾病. 在患者细胞中抑制表皮生长因子受体 (EGFR) 恢复了德斯莫普拉金功能,这表明了与DSP相关的疾病的潜在治疗策略.
科学领域:
- 遗传学和分子生物学
- 皮肤病学 皮肤病学
- 心脏病学 心脏病学
背景情况:
- 德斯莫普拉金 (DSP) 对于皮肤和心脏组织中的德斯莫体稳定性和中间线索连接至关重要.
- 在DSP基因的致病变体导致不同的表型,包括棕植物皮病 (PPK),羊毛 (WH),心肌病 (ACM/DCM).
- 对DSP变种致病性的预测分析往往含糊不清,需要进行功能性研究.
研究的目的:
- 在一个患有PPK,WH和ACM的患者中发现的一种新型异质合体DSP变体 (NM_004415.4:c.3337C>T) 的功能性特征.
- 为了研究表皮生长因子受体 (EGFR) 在与 DSP 随机缺陷相关的细胞表型中的作用.
- 探索EGFR抑制对DSP相关疾病的治疗潜力.
主要方法:
- 在患者衍生细胞中对DSP的RNA和蛋白质表达分析.
- 评估角质细胞细胞连接和中间丝组织.
- 用EGFR抑制剂对患者的角质细胞进行体外治疗,随后对DSP局部化和脱体形成进行分析.
主要成果:
- 新型DSP变异导致DSPmRNA和蛋白质水平减少约50%.
- 患者的角质细胞表现出脆弱的细胞-细胞结点和收缩的中间纤维.
- 在患者的角质细胞中EGFR抑制导致了在血膜上增加DSP表达,改善了中间丝的附着,降低了细胞脆弱性,并增强了脱体的形成.
结论:
- 鉴定到的DSP变体导致了哈普洛缺陷,导致了角质细胞的细胞缺陷.
- EGFR在受影响的皮肤上升调节,并在DSP相关的细胞表型中发挥作用.
- EGFR抑制通过恢复 DSP 功能和改善 DSP 脱素不足障碍的细胞完整性来证明其治疗潜力.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Renewal of Skin Epidermal Stem Cells
2.5K
The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular...
2.5K
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K


